About
Technology
Issues
FAQ
Links
Official Page
Daratumumab depletes CD38+ immune regulatory cells, promotes T-cell expansion, and skews T-cell repertoire in multiple myeloma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.